RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.18%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.19B
AUM Growth
+$4.19B
(+0.79%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
124
New
3
Increased
47
Reduced
8
Closed
3
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$18.3M |
| 2 |
Biomea Fusion
BMEA
|
$17.6M |
| 3 |
Revolution Medicines
RVMD
|
$15.2M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$14.5M |
| 5 |
Pliant Therapeutics
PLRX
|
$13.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$58.6M |
| 2 |
Penumbra
PEN
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$18.4M |
| 4 |
Immunocore
IMCR
|
$15.8M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 97.18% |
| 2 | Consumer Staples | 1.05% |
| 3 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Humana
HUM
$36.5B
| $207M | 4.94% | 426,500 | – | – |
|
2
Agilon Health
AGL
$530M
| $187M | 4.47% | 7,882,500 +10,000 | +0.1% | +$238K |
|
3
Insulet
PODD
$23.9B
| $171M | 4.08% | 536,750 +12,500 | +2% | +$3.99M |
|
|
4
Immunocore
IMCR
$1.62B
| $148M | 3.54% | 3,001,662 -319,404 | -10% | -$15.8M |
|
5
argenx
ARGX
$43.6B
| $130M | 3.11% | 350,000 | – | – |
|
6
UnitedHealth
UNH
$281B
| $128M | 3.04% | 270,000 | – | – |
|
7
Evolent Health
EVH
$1.12B
| $123M | 2.94% | 3,803,500 | – | – |
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $122M | 2.92% | 1,210,100 +87,600 | +8% | +$8.87M |
|
|
9
Penumbra
PEN
$10.6B
| $121M | 2.88% | 433,500 -74,750 | -15% | -$20.8M |
|
|
RXDX
10
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $111M | 2.64% | 1,031,550 | – | – |
|
11
Idexx Laboratories
IDXX
$51.8B
| $104M | 2.48% | 207,500 | – | – |
|
|
BPMC
12
DELISTED
Blueprint Medicines
BPMC
| $91.5M | 2.18% | 2,033,048 +141,538 | +7% | +$6.37M |
|
|
KRTX
13
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $89.6M | 2.14% | 493,527 +79,765 | +19% | +$14.5M |
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $84.3M | 2.01% | 348,121 | – | – |
|
|
15
Align Technology
ALGN
$10.3B
| $82.6M | 1.97% | 247,350 -55,000 | -18% | -$18.4M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $81M | 1.93% | 400,200 | – | – |
|
|
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $80.8M | 1.93% | 740,100 +400 | +0.1% | +$43.7K |
|
18
Intuitive Surgical
ISRG
$170B
| $76.3M | 1.82% | 298,500 | – | – |
|
19
West Pharmaceutical
WST
$17.8B
| $70M | 1.67% | 202,000 +16,500 | +9% | +$5.72M |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $69.1M | 1.65% | 345,000 +12,500 | +4% | +$2.5M |
|
21
Exact Sciences
EXAS
$8.98B
| $63.8M | 1.52% | 941,500 +54,000 | +6% | +$3.66M |
|
22
Acadia Healthcare
ACHC
$2.12B
| $62.2M | 1.48% | 860,868 +15,368 | +2% | +$1.11M |
|
|
CERE
23
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $61.3M | 1.46% | 2,513,916 +7,452 | +0.3% | +$182K |
|
24
Agios Pharmaceuticals
AGIO
$2.19B
| $61.1M | 1.46% | 2,661,605 -334,987 | -11% | -$7.69M |
|
25
Sarepta Therapeutics
SRPT
$1.78B
| $61M | 1.46% | 442,500 +6,500 | +1% | +$896K |
|